Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,923 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,503
Recruiting: 783
Ph III recruiting: 85
Growth YoY: +18.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (759)

clinicaltrialsPublishedShowing 401–450 of 2,132 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00715442	Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)	active not recruiting	Phase 2	50	M.D. Anderson Cancer CenterOTHER	1	Jun 12, 2026	clinicaltrials
NCT05639972	E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers	recruiting	Phase 1 / Phase 2	15	Christian HinrichsOTHER	1	Jun 12, 2026	clinicaltrials